Winton Group LTD Cor Medix Inc. Transaction History

Winton Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$5.0 - $9.15 $312,275 - $571,463	-62,455 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$3.96 - $6.15 $247,321 - $384,098	62,455 New	62,455 $377,000
Q3 2019 Nov 08, 2019	SELL	$6.38 - $9.69 $64,170 - $97,462	-10,058 Closed	0 $0
Q2 2019 Jul 08, 2019	BUY	$5.93 - $10.57 $59,643 - $106,313	10,058 New	10,058 $90,000

112

17.7M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $464M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.